Dr. Richard P. Lifton - The City College Fund

PRESIDENT LISA S. COICO
THE CITY COLLEGE FUND
INVITE YOU TO JOIN CITY COLLEGE FACULTY, ALUMNI, STUDENTS AND STAFF
FOR THE ANNUAL LECTURE OF
AND
THE LOUIS LEVINE-GABRIELLA DE BEER
LECTURE IN GENETICS
Dr. Richard P. Lifton
WITH
CHAIR, DEPARTMENT OF GENETICS
HOWARD HUGHES MEDICAL INSTITUTE
YALE SCHOOL OF MEDICINE
GENOMIC APPROACHES TO UNDERSTAND
HYPERTENSION AND OTHER COMMON DISEASES
Please call
The City College Fund for directions by car
or public transportation,
or with questions regarding parking.
212-650-7192
aLimited on-campus parking is available.b
A CCNY marked bus to the campus is scheduled to stop at the
subway station at 145th & St. Nicholas Ave. every 15 minutes.
THURSDAY, MARCH 27, 2014, 5:00PM
RECEPTION TO FOLLOW
THE GREAT HALL OF SHEPARD HALL,
THE CITY COLLEGE OF NEW YORK
160 CONVENT AVENUE AT 138TH STREET
NEW YORK, NEW YORK
RSVP BY MARCH 17, 2014
(212) 650-7192
OR [email protected]
THE LOUIS LEVINE-GABRIELLA DE BEER
LECTURE IN GENETICS
The Louis Levine-Gabriella de Beer Lecture in Genetics
was established by Gabriella de Beer in memory of her
husband, Professor Louis Levine. A graduate of the College,
he earned his Ph.D. in population genetics under the late
great evolutionary geneticist Theodosius Dobzhansky at
Columbia University. Professor Levine’s research centered on
population studies of Drosophila and behavior genetics of
mice. Human genetics and forensic genetics were among
other areas to which he was devoted. Professor Levine taught
in the Department of Biology and in the Sophie Davis School
of Biomedical Education, participated in bi-national research
studies in Mexico, was Visiting Professor at the Technion
(the Israel Institute of Technology) in Israel, and in later
years served as a consultant and expert witness in criminal
cases involving DNA evidence.
The aim of these annual lectures is to perpetuate Professor
Louis Levine’s lifelong interest in the ever-expanding field of
genetics.
Thursday, March 27, 2014
DR. RICHARD P. LIFTON
Dr. Richard P. Lifton is Chairman of the Department of
Genetics, Sterling Professor of Genetics and Internal Medicine,
Executive Director of the Yale Center for Genome Analysis, and
Investigator of the Howard Hughes Medical Institute at Yale
University School of Medicine. He received his B.A. in Biology from
Dartmouth, M.D. and Ph.D. in Biochemistry from Stanford, and was
Resident and Chief Resident in Internal Medicine at Brigham and
Women’s Hospital prior to moving to Yale in 1993.
Dr. Lifton’s laboratory has used human genetics and genomics
to identify key genes and pathways that underlie hypertension and
other diseases including cardiovascular disease and cancer. These
findings have provided new preventive, diagnostic, and therapeutic
approaches to these diseases. In particular, his work on hypertension
has provided the scientific basis for worldwide efforts to limit dietary
salt intake to reduce morbidity and mortality and has identified new
targets for therapeutic intervention that are in clinical development.
Dr. Lifton serves on the Governing Council of the National
Academy of Sciences, on the Lasker Awards Jury, and on the scientific
Advisory Boards of Merck, the Broad Institute of Harvard and MIT, the
Whitehead Institute of MIT, the JPB Foundation, and the
Massachusetts General Hospital. His honors include election to the
National Academy of Sciences, the Institute of Medicine, and the
American Academy of Arts and Sciences. He has received the Wiley
Prize in Biomedical Sciences and the highest scientific awards of the
American Heart Association, the American Society of Nephrology, the
Council for High Blood Pressure Research, the American Society of
Hypertension, the Endocrine Society, the International Society of
Hypertension, and the International Society of Nephrology. Most
recently, he received the 2014 Breakthrough Prize in the Life Sciences.
THE LOUIS LEVINE-GABRIELLA DE BEER
LECTURE IN GENETICS
The Louis Levine-Gabriella de Beer Lecture in Genetics
was established by Gabriella de Beer in memory of her
husband, Professor Louis Levine. A graduate of the College,
he earned his Ph.D. in population genetics under the late
great evolutionary geneticist Theodosius Dobzhansky at
Columbia University. Professor Levine’s research centered on
population studies of Drosophila and behavior genetics of
mice. Human genetics and forensic genetics were among
other areas to which he was devoted. Professor Levine taught
in the Department of Biology and in the Sophie Davis School
of Biomedical Education, participated in bi-national research
studies in Mexico, was Visiting Professor at the Technion
(the Israel Institute of Technology) in Israel, and in later
years served as a consultant and expert witness in criminal
cases involving DNA evidence.
The aim of these annual lectures is to perpetuate Professor
Louis Levine’s lifelong interest in the ever-expanding field of
genetics.
Thursday, March 27, 2014
DR. RICHARD P. LIFTON
Dr. Richard P. Lifton is Chairman of the Department of
Genetics, Sterling Professor of Genetics and Internal Medicine,
Executive Director of the Yale Center for Genome Analysis, and
Investigator of the Howard Hughes Medical Institute at Yale
University School of Medicine. He received his B.A. in Biology from
Dartmouth, M.D. and Ph.D. in Biochemistry from Stanford, and was
Resident and Chief Resident in Internal Medicine at Brigham and
Women’s Hospital prior to moving to Yale in 1993.
Dr. Lifton’s laboratory has used human genetics and genomics
to identify key genes and pathways that underlie hypertension and
other diseases including cardiovascular disease and cancer. These
findings have provided new preventive, diagnostic, and therapeutic
approaches to these diseases. In particular, his work on hypertension
has provided the scientific basis for worldwide efforts to limit dietary
salt intake to reduce morbidity and mortality and has identified new
targets for therapeutic intervention that are in clinical development.
Dr. Lifton serves on the Governing Council of the National
Academy of Sciences, on the Lasker Awards Jury, and on the scientific
Advisory Boards of Merck, the Broad Institute of Harvard and MIT, the
Whitehead Institute of MIT, the JPB Foundation, and the
Massachusetts General Hospital. His honors include election to the
National Academy of Sciences, the Institute of Medicine, and the
American Academy of Arts and Sciences. He has received the Wiley
Prize in Biomedical Sciences and the highest scientific awards of the
American Heart Association, the American Society of Nephrology, the
Council for High Blood Pressure Research, the American Society of
Hypertension, the Endocrine Society, the International Society of
Hypertension, and the International Society of Nephrology. Most
recently, he received the 2014 Breakthrough Prize in the Life Sciences.

Download Report